Pfizer Inc. (ETR:PFE)
24.95
+0.08 (0.32%)
Feb 21, 2025, 5:41 PM CET
Pfizer Employees
Pfizer had 88,000 employees as of December 31, 2023. The number of employees increased by 5,000 or 6.02% compared to the previous year.
Employees
88,000
Change (1Y)
5,000
Growth (1Y)
6.02%
Revenue / Employee
€698,379
Profits / Employee
€88,149
Market Cap
142.60B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 88,000 | 5,000 | 6.02% |
Dec 31, 2022 | 83,000 | 4,000 | 5.06% |
Dec 31, 2021 | 79,000 | 500 | 0.64% |
Dec 31, 2020 | 78,500 | -9,800 | -11.10% |
Dec 31, 2019 | 88,300 | -4,100 | -4.44% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 62,908 |
Bayer Aktiengesellschaft | 96,931 |
Fresenius SE & Co. KGaA | 193,865 |
Sartorius Aktiengesellschaft | 13,528 |
Fresenius Medical Care AG | 119,845 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 23,412 |
Pfizer News
- 12 hours ago - Pfizer: No More Growth - Still A Worthy Dividend Buy - Seeking Alpha
- 1 day ago - Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes - Benzinga
- 1 day ago - Pfizer: Investors Won't Stick Around Forever - Seeking Alpha
- 1 day ago - Pfizer board approves marketing and supply agreement with Mylan Pharmaceuticals for Ativan and Pacitane in India - Business Upturn
- 2 days ago - Pfizer said to be discontinuing Roche-partnered hemophilia therapy Beqvez - Seeking Alpha
- 2 days ago - Pfizer says it will end global development of gene therapy Beqvez, Nikkei reports - Reuters
- 2 days ago - Dividend Harvesting Portfolio Week 207: $20,700 Allocated, $2,010.09 In Projected Dividends - Seeking Alpha
- 3 days ago - 10 Ideal 'Safer' January Dividend Buys, Out Of 40 Choices From Readers - Seeking Alpha